Global Implantable Biomaterials Market (2021 to 2030) – Featuring Evonik Industries, Royal DSM and Corbion Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Implantable Biomaterials Global Market Report 2021: COVID-19 Growth and Change to 2030” report has been added to ResearchAndMarkets.com’s offering.
This report provides the strategists, marketers and senior management with the critical information they need to assess the global implantable biomaterials market.
The global implantable biomaterials market is expected to grow from $103.9 billion in 2020 to $114.35 billion in 2021 at a compound annual growth rate (CAGR) of 10.1%.
The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $161.22 billion in 2025 at a CAGR of 9%.
Companies Mentioned
- Evonik Industries AG
- Royal DSM
- Zimmer Biomet Holdings
- Carpenter Technology Corporation
- Collagen Matrix
- Corbion
- BASF SE
- Invibio Ltd.
- Celanese Corporation
- Cam Bioceramics B.V.
- E. I. Du Pont De Nemours and Company
- AdvanSource Biomaterials Corporation
- Wright Medical Technology
- Berkeley Advanced Biomaterials
- Collagen solutions Plc
- Keystone Dental
- Surgival
- SBM France
- 3M
- Biomet
- Orthofix Holdings
- Stryker Corporation
- KLS martin and Medtronic
- Arthrex
- Aap Implantate AG
- CoorsTek Inc.
- CeramTec
- GELITA AG
- DePuy Synthes Companies
- Bayer AG
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
The implantable biomaterials market consists of sales of implantable biomaterials and related services. A biomaterial is a natural or synthetic material that is used in medical applications to support, enhance, or replace the damaged tissue or a biological structure.
The implantable biomaterials market covered in this report is segmented by material into metallic, ceramic, polymers, natural and by application into dental, cardiovascular, ophthalmology, orthopedic, others.
The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Limitations of biomaterial-based products is a major challenge for the implantable biomaterials market. For instance, metal biomaterials can corrode due to chemical reactions within the body such as enzymes and acids or it can also cause some metal ion toxicity in the body. Polymer biomaterial implants have intensive interaction with the body and can lead to wear and tear and can absorb the important nutrients and water from the blood. Some biomaterial implants can also minimize bone ingrowth or sometimes, implants can loosen over time and become dislodged. These reactions that biomaterials have with the body restrain their use thereby negatively impacting the implantable biomaterials market’s growth.
The allocation of funds by government organizations in the development of new biomaterials contributed to the implantable biomaterials market’s growth.
Major companies in the implantable biomaterials market are implementing 3D printing of biomaterials in manufacturing. For instance, Evonik is producing 3D printable biomaterials for medical technology that are used for manufacturing medical implants with permanent body contact and temporary body contactline of bioresorbable filaments and powders. Implants with permanent body contact are based on Vestakeep Peek, and with temporary body contact are based on Resomer.
The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
For more information about this report visit https://www.researchandmarkets.com/r/b0k4fz
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
